Low-endotoxin γ-polyglutamic acid, and separation and extraction method therefor and use thereof
Through the combination technology of microfiltration membrane, ultrafiltration membrane and nanofiltration membrane, the problems of endotoxin removal and purity improvement in the γ-polyglutamic acid extraction process are solved, and efficient and safe γ-polyglutamic acid separation and extraction are achieved. , improves the purity and utilization of the product.
Patent Information
- Application Number
- PCT/CN2023/106029
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-06-09
- Filing Date
- 2023-07-06
- Publication Date
- 2024-12-12
AI Technical Summary
In the prior art, the extraction process of γ-polyglutamic acid is immature, especially in pharmaceutical use, it is difficult to effectively remove harmful endotoxins in the human body, and the product purity and utilization rate are relatively low.
The combination of microfiltration membrane, ultrafiltration membrane and nanofiltration membrane is used to separate and extract polyglutamic acid, including microfiltration removal of bacteria, ultrafiltration grading, activated carbon decolorization and removal of endotoxins, etc., through physical methods and whole water The ethanol-free extraction method ensures high purity and low endotoxins of the product.
Improve the purity and utilization rate of polyglutamic acid, reduce production costs, and realize efficient, safe and continuous extraction process. The product's endotoxin content is less than 0.5EU/g, the purity reaches 101-104%, and the product is improved. quality and recovery rate.
Smart Images

Figure CN2023106029_12122024_PF_FP_ABST
Abstract
Description
A low-endotoxin gamma-polyglutamic acid and its separation and extraction method and application Technical Field
[0001] The present invention relates to the technical field of separation and extraction of gamma-polyglutamic acid, and more particularly to low-endotoxin gamma-polyglutamic acid and a separation and extraction method and application thereof. Background Art
[0002] Polyglutamic acid (PGA) is an amide-bonded polyamino acid polymer formed by the polymerization of L- and D-glutamic acids through amide bonds. It is biodegradable under certain conditions. Polyglutamic acid is typically composed of 500-5,000 glutamic acid monomers, with a molecular weight ranging from approximately 100,000 to 2,000,000. Existing research demonstrates that PGA exhibits excellent water solubility, biodegradability, edibility, film-forming properties, and moisture retention, leading to its widespread application in industries such as agriculture, food, cosmetics, and materials.
[0003] Polyglutamic acid production and research in my country is relatively new. Currently, its applications are primarily in agriculture and cosmetics, with limited application in medical devices. Overall, the research phase remains ongoing, and the extraction process is immature. The extraction process for pharmaceutical γ-polyglutamic acid prioritizes seamless coordination between extraction steps, minimizing harmful endotoxins and other pyrogens, while simultaneously enhancing product purity.
[0004] In view of this, the present invention is proposed.
[0005] Summary of the Invention
[0006] In order to solve the problems existing in the above technologies, the present invention provides a low-endotoxin γ-polyglutamic acid and a separation and extraction method and application thereof.
[0007] To achieve the above object, the technical solution of the present invention is as follows:
[0008] In one aspect, the present invention provides a method for separating and extracting low-endotoxin γ-polyglutamic acid, comprising the following steps:
[0009] S1, microfiltration membrane to remove bacteria
[0010] The fermented polyglutamic acid mixture is added to a hollow fiber microfiltration membrane, circulated and pressurized to separate the solid and liquid of the polyglutamic acid fermentation liquid, and the polyglutamic acid permeate is collected;
[0011] S2, ultrafiltration membrane ultrafiltration
[0012] The polyglutamic acid permeate is repeatedly ultrafiltered using an ultrafiltration membrane to collect the polyglutamic acid fermentation liquid with a molecular weight of 500-1000 kD;
[0013] S3, activated carbon decolorization
[0014] Adding H2SO4 solution to the polyglutamic acid fermentation broth until its pH reaches 4-5, then adding powdered activated carbon, heating and stirring to decolorize, filtering to remove the activated carbon, and obtaining a colorless fermentation broth;
[0015] S4, nanofiltration and concentration
[0016] The colorless fermentation broth was repeatedly intercepted and desalted using a nanofiltration membrane, and then concentrated to obtain a polyglutamic acid concentrate with a concentration of 5-7 g / 100 mL;
[0017] S5. Remove endotoxins
[0018] Adjusting the pH of the polyglutamic acid concentrate to 5.0-5.5, then adding medicinal activated carbon, heating and stirring to remove endotoxins, and filtering to remove the medicinal activated carbon;
[0019] S6. Post-processing
[0020] Vacuum freeze drying, crushing, sterilization and packaging are completed.
[0021] In the above technical solution, in step S3, the concentration of the H2SO4 solution is 6-10 mol / L.
[0022] In the above technical solution, in step S3, the amount of powdered activated carbon added is 15-25 g / L.
[0023] In the above technical solution, in step S3, the stirring speed, temperature and time of the heating and stirring decolorization are 100-180 rpm, 35-45° C. and 30-60 min respectively.
[0024] In the above technical solution, in step S5, the pH of the polyglutamic acid concentrate is adjusted by adding H2SO4 solution.
[0025] In the above technical solution, in step S5, the type and addition amount of the medicinal activated carbon are 767 medicinal activated carbon and 5-10 g / L, respectively.
[0026] In the above technical solution, in step S5, the stirring speed, temperature and time for heating and stirring to remove endotoxin are 120-150 rpm, 40-45°C and 30-60 min respectively.
[0027] Furthermore, in the above technical solution, in step S1, before adding the polyglutamic acid mixture to the hollow fiber microfiltration membrane, the viscosity of the mixture is adjusted to 50-70 MPa·s by adding water.
[0028] Furthermore, in the above technical solution, in step S1, the pore size of the hollow fiber membrane microfiltration membrane is 50-80 nm.
[0029] In a preferred embodiment of the present invention, in step S1, during the circulation and pressurization process, the pressures of the feed port and the discharge port are controlled to be 0.12-0.18 MPa and 0.09-0.12 MPa, respectively, and the number of circulation and pressurization is 3-5 times.
[0030] Furthermore, in the above technical solution, step S2 specifically includes first performing ultrafiltration through an ultrafiltration membrane with a molecular weight cutoff of 500KD to obtain a polyglutamic acid fermentation broth with a molecular weight greater than 500KD, and then ultrafiltration through an ultrafiltration membrane with a molecular weight cutoff of 1000KD to obtain a polyglutamic acid fermentation broth with a molecular weight of 500-1000KD.
[0031] Furthermore, in the above technical solution, in step S4, a colorless fermentation broth is taken, water is added, and a nanofiltration membrane assembly with a molecular weight cutoff of 500-1000 Da is used, the operating pressure is controlled to be 0.1-0.5 MPa, and the salt is intercepted and desalted 5-8 times until the conductivity of the permeate is 20-100 μs / cm and the glutamic acid content is less than 5 wt%.
[0032] Furthermore, in the above technical solution, in step S6, the vacuum freeze-drying specifically includes:
[0033] First pre-freeze at -80℃ for 12-18h, then use a freeze dryer to freeze at a cold trap temperature of -65℃ for 12-18h.
[0034] Another aspect of the present invention provides low-endotoxin gamma-polyglutamic acid prepared by the above separation and extraction method.
[0035] Specifically, based on commercially available cosmetic grade, the purity of the low-endotoxin γ-polyglutamic acid is 101-104%, and its endotoxin is less than 0.5 EU / g.
[0036] In another aspect, the present invention provides the use of the above separation and extraction method or the above low-endotoxin γ-polyglutamic acid in the preparation of pharmaceutical-grade γ-polyglutamic acid products.
[0037] Compared with the prior art, the present invention has the following advantages:
[0038] (1) The separation and extraction method provided by the present invention uses a microfiltration membrane to remove the bacteria, uses physical methods, does not introduce new impurities, and can efficiently and quickly separate the fermentation bacteria. The retentate (bacteria-carrying liquid) can be used as polyglutamic acid for agricultural use, thereby improving the utilization recovery rate of polyglutamic acid.
[0039] (2) The separation and extraction method provided by the present invention performs ultrafiltration classification on the fermentation broth, which not only can obtain polyglutamic acid of different molecular weights, but also can decolorize the fermentation broth and remove ions and small molecular proteins, thereby reducing the pressure of downstream decolorization and desalination concentration, and at the same time improving the quality of the product. That is, the ultrafiltration membrane separation technology of high molecular target substances is used to specifically separate and purify the target substance, thereby reducing process costs;
[0040] (3) The separation and extraction method provided by the present invention adopts a fully hydrated alcohol-free extraction method and combines microfiltration membrane, ultrafiltration membrane and nanofiltration membrane to achieve high purification efficiency and high product purity. It also avoids the growth of endotoxins in the downstream separation process and maintains a low-endotoxin fermentation broth state in the downstream extraction process.
[0041] (4) The purity of the polyglutamic acid prepared by the separation and extraction method provided by the present invention is higher than that of commercially available polyglutamic acid, the production cost is low, and the production process is safe, efficient, continuous and automated. The product yield can reach 80-85%, the endotoxin content is 0.2-0.4 EU / g, and the purity is 101-104% (based on commercially available cosmetic grade). BRIEF DESCRIPTION OF THE DRAWINGS
[0042] FIG1 is a process flow chart of the method for separating and extracting low-endotoxin γ-polyglutamic acid in an embodiment of the present invention. DETAILED DESCRIPTION
[0043] In order to make the purpose, technical solutions and advantages of the present invention more clear, the present invention is further described in detail below with reference to the embodiments.
[0044] It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
[0045] In the examples, unless otherwise specified, all means used are conventional means in the art.
[0046] As used herein, the terms "comprise," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus that comprises a listed element is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus.
[0047] In addition, the technical features involved in the various embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other. In the following examples of the present invention, the raw materials used are all commercially available products and are used directly without special treatment.
[0048] The fermentation process of the polyglutamic acid mixed solution used in the embodiment of the present invention includes:
[0049] (1) Produced by fermentation with Bacillus licheniformis 11052 as the production strain, strain deposit number CGMCC No. 23967;
[0050] (2) Bacillus licheniformis 11052 was inoculated into a seed culture medium at an inoculum size of 3%, and cultured in a shaking incubator at 37°C and 220 rpm until the OD660 reached 0.1 to prepare a seed culture solution;
[0051] (3) The seed culture solution was inoculated into the fermentation medium at an inoculation amount of 10%, and the fermentation tank was aerated and stirred at 37° C. for 72 h to obtain polyglutamic acid fermentation solution.
[0052] Example 1
[0053] The embodiment of the present invention provides a method for separating and extracting low-endotoxin γ-polyglutamic acid, as shown in FIG1 , which specifically includes the following steps:
[0054] S1, microfiltration membrane to remove bacteria
[0055] Take the newly fermented polyglutamic acid mixture, dilute it with water to a viscosity of 50 MPa·s, select a hollow fiber microfiltration membrane with a pore size of 60 nm, add it, and control the pressure of the feed port and discharge port to 0.15 MPa and 0.1 MPa respectively. Cycle water elution four times, and collect the polyglutamic acid permeate;
[0056] S2, ultrafiltration membrane ultrafiltration
[0057] The polyglutamic acid permeate in step S1 is ultrafiltered through an ultrafiltration membrane with a molecular weight cutoff of 500 kD to obtain a polyglutamic acid fermentation broth with a molecular weight greater than 500 kD, and then ultrafiltered through a 1000 kD ultrafiltration membrane to obtain a polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD;
[0058] S3, activated carbon decolorization
[0059] 6 mol / L H2SO4 was added to the polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD obtained in step S2 to adjust the pH thereof to 4, followed by the addition of 15 g / L powdered activated carbon. The mixture was subjected to adsorption treatment at a stirring speed of 120 r / min and 40° C. for 30 min to remove the pigment in the polyglutamic acid fermentation broth. Finally, the activated carbon was removed by filtration to obtain a colorless fermentation broth.
[0060] S4, nanofiltration and concentration
[0061] The colorless fermentation broth was subjected to combined nanofiltration desalination through nanofiltration membrane modules with molecular weight cutoffs of 500 Da and 1000 Da. The operating pressure was controlled at 0.2 MPa, and water (freshly prepared deionized water) was repeatedly added thereto in a volume of 0.5 times that of the colorless fermentation broth. The nanofiltration was repeated 5 times until the conductivity of the permeate reached 20-100 μs / cm, the glutamic acid content was less than 5%, and the solution concentration reached 7 g / 100 ml.
[0062] S5. Remove endotoxins
[0063] The pH of the polyglutamic acid concentrate was adjusted to 5.0 by adding H2SO4 solution (4 mol / L), and then 5 g / L of 767 type medicinal activated carbon was added. The mixture was adsorbed at a stirring speed of 120 r / min and 40°C for 30 min, and the endotoxin was removed by heating. The 767 type medicinal activated carbon was then removed by filtration.
[0064] S6. Post-processing
[0065] After pre-cooling at -80℃ for 12 hours, use a freeze dryer to freeze-dry at a cold trap temperature of -65℃ for 12 hours. After collection, crush, sterilize and package.
[0066] Example 2
[0067] The embodiment of the present invention provides a method for separating and extracting low-endotoxin γ-polyglutamic acid, which specifically includes the following steps:
[0068] S1, microfiltration membrane to remove bacteria
[0069] Take the newly fermented polyglutamic acid mixture, dilute it with water to a viscosity of 60 MPa·s, select a hollow fiber microfiltration membrane with a pore size of 60 nm, add it, and control the feed port pressure and discharge port pressure to 0.15 MPa and 0.1 MPa respectively. Cycle water elution four times, and collect the polyglutamic acid permeate;
[0070] S2, ultrafiltration membrane ultrafiltration
[0071] The polyglutamic acid permeate in step S1 is ultrafiltered through an ultrafiltration membrane with a molecular weight cutoff of 500 kD to obtain a polyglutamic acid fermentation broth with a molecular weight greater than 500 kD, and then ultrafiltered through a 1000 kD ultrafiltration membrane to obtain a polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD;
[0072] S3, activated carbon decolorization
[0073] 8 mol / L H2SO4 was added to the polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD obtained in step S2 to adjust the pH thereof to 4.5, followed by the addition of 20 g / L powdered activated carbon. The mixture was subjected to adsorption treatment at a stirring speed of 140 r / min and 50° C. for 60 min to remove the pigment in the polyglutamic acid fermentation broth, and finally the activated carbon was removed by filtration to obtain a colorless fermentation broth.
[0074] S4, nanofiltration and concentration
[0075] The colorless fermentation broth was subjected to combined nanofiltration desalination through nanofiltration membrane modules with molecular weight cutoffs of 500 Da and 1000 Da. The operating pressure was controlled at 0.4 MPa, and water (freshly prepared deionized water) was repeatedly added thereto in a volume 1.0 times that of the colorless fermentation broth. The nanofiltration was repeated 7 times until the conductivity of the permeate was 20-100 μs / cm, the glutamic acid content was less than 5%, and the solution concentration reached 5 g / 100 ml.
[0076] S5. Remove endotoxins
[0077] The pH of the polyglutamic acid concentrate was adjusted to 5.5 by adding H2SO4 solution (6 mol / L), followed by adding 10 g / L of 767 type medicinal activated carbon, and adsorption treatment was carried out at a stirring speed of 150 r / min and 45°C for 60 min. The endotoxin was removed by heat preservation, and the 767 type medicinal activated carbon was removed by filtration;
[0078] S6. Post-processing
[0079] After pre-cooling at -80℃ for 12 hours, use a freeze dryer to freeze-dry at a cold trap temperature of -65℃ for 12 hours. After collection, crush, sterilize and package.
[0080] Example 3
[0081] The embodiment of the present invention provides a method for separating and extracting low-endotoxin γ-polyglutamic acid, which specifically includes the following steps:
[0082] S1, microfiltration membrane to remove bacteria
[0083] Take the newly fermented polyglutamic acid mixture, dilute it with water to a viscosity of 70 MPa·s, select a hollow fiber microfiltration membrane with a pore size of 60 nm, add it, and control the feed port pressure and discharge port pressure to 0.15 MPa and 0.1 MPa respectively. Cycle water elution four times, and collect the polyglutamic acid permeate;
[0084] S2, ultrafiltration membrane ultrafiltration
[0085] The polyglutamic acid permeate in step S1 is ultrafiltered through an ultrafiltration membrane with a molecular weight cutoff of 500 kD to obtain a polyglutamic acid fermentation broth with a molecular weight greater than 500 kD, and then ultrafiltered through a 1000 kD ultrafiltration membrane to obtain a polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD;
[0086] S3, activated carbon decolorization
[0087] 10 mol / L H2SO4 was added to the polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD obtained in step S2 to adjust the pH thereof to 5, followed by addition of 25 g / L powdered activated carbon. The mixture was subjected to adsorption treatment at a stirring speed of 150 r / min and 40° C. for 45 min to remove the pigment in the polyglutamic acid fermentation broth, and finally filtered to remove the activated carbon to obtain a colorless fermentation broth.
[0088] S4, nanofiltration and concentration
[0089] The colorless fermentation broth was subjected to combined nanofiltration desalination through nanofiltration membrane modules with molecular weight cutoffs of 500 Da and 1000 Da. The operating pressure was controlled at 0.5 MPa, and water (freshly prepared deionized water) was repeatedly added thereto in a volume 1.0 times that of the colorless fermentation broth. The nanofiltration was repeated 7 times until the conductivity of the permeate reached 20-100 μs / cm, the glutamic acid content was less than 5%, and the solution concentration reached 6 g / 100 ml.
[0090] S5. Remove endotoxins
[0091] The pH of the polyglutamic acid concentrate was adjusted to 5.0 by adding H2SO4 solution (5 mol / L), followed by adding 7 g / L of 767 type medicinal activated carbon. The mixture was stirred at 150 r / min and 40°C for 60 min for adsorption. The mixture was kept warm to remove endotoxins, and the 767 type medicinal activated carbon was removed by filtration.
[0092] S6. Post-processing
[0093] After pre-cooling at -80℃ for 12 hours, use a freeze dryer to freeze-dry at a cold trap temperature of -65℃ for 12 hours. After collection, crush, sterilize and package.
[0094] Example 4
[0095] The embodiment of the present invention provides a method for separating and extracting low-endotoxin γ-polyglutamic acid, which specifically includes the following steps:
[0096] S1, microfiltration membrane to remove bacteria
[0097] Take the newly fermented polyglutamic acid mixture, dilute it with water to a viscosity of 70 MPa·s, select a hollow fiber microfiltration membrane with a pore size of 60 nm, add it, and control the feed port pressure and discharge port pressure to 0.15 MPa and 0.1 MPa respectively. Cycle water elution four times, and collect the polyglutamic acid permeate;
[0098] S2, ultrafiltration membrane ultrafiltration
[0099] The polyglutamic acid permeate in step S1 is ultrafiltered through an ultrafiltration membrane with a molecular weight cutoff of 500 kD to obtain a polyglutamic acid fermentation broth with a molecular weight greater than 500 kD, and then ultrafiltered through a 1000 kD ultrafiltration membrane to obtain a polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD;
[0100] S3, nanofiltration and concentration
[0101] A polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD was subjected to combined nanofiltration desalination through nanofiltration membrane modules with molecular weight cutoffs of 500 Da and 1000 Da. The operating pressure was controlled at 0.5 MPa, and water (freshly prepared deionized water) was repeatedly added to the broth at a volume 1.0 times that of the polyglutamic acid fermentation broth. Nanofiltration was repeated seven times until the conductivity of the permeate reached 20-100 μs / cm, the glutamic acid content was less than 5%, and the solution concentration reached 7 g / 100 ml.
[0102] S4, activated carbon decolorization
[0103] 10 mol / L H2SO4 was added to the polyglutamic acid fermentation broth after the treatment in step S3 to adjust the pH thereof to 5, followed by the addition of 15 g / L powdered activated carbon. The mixture was stirred at a speed of 150 r / min and a temperature of 40°C for 45 minutes to remove the pigment from the polyglutamic acid fermentation broth. The activated carbon was then removed by filtration to obtain a colorless fermentation broth.
[0104] S5. Remove endotoxins
[0105] The pH of the polyglutamic acid concentrate was adjusted to 5.3 by adding H2SO4 solution (5.5 mol / L), and then 10 g / L of 767 type medicinal activated carbon was added. The mixture was adsorbed at a stirring speed of 150 r / min and 40°C for 60 min, and the endotoxin was removed by heating. The 767 type medicinal activated carbon was removed by filtration.
[0106] S6. Post-processing
[0107] After pre-cooling at -80℃ for 12 hours, use a freeze dryer to freeze-dry at a cold trap temperature of -65℃ for 12 hours. After collection, crush, sterilize and package.
[0108] Example 5
[0109] The embodiment of the present invention provides a method for separating and extracting low-endotoxin γ-polyglutamic acid, which specifically includes the following steps:
[0110] S1, microfiltration membrane to remove bacteria
[0111] Take the newly fermented polyglutamic acid mixture, dilute it with water to a viscosity of 70 MPa·s, select a hollow fiber microfiltration membrane with a pore size of 60 nm, add it, and control the feed port pressure and discharge port pressure to 0.15 MPa and 0.1 MPa respectively. Cycle water elution four times, and collect the polyglutamic acid permeate;
[0112] S2, ultrafiltration membrane ultrafiltration
[0113] The polyglutamic acid permeate in step S1 is ultrafiltered through an ultrafiltration membrane with a molecular weight cutoff of 500 kD to obtain a polyglutamic acid fermentation broth with a molecular weight greater than 500 kD, and then ultrafiltered through a 1000 kD ultrafiltration membrane to obtain a polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD;
[0114] S3, activated carbon decolorization
[0115] 10 mol / L H2SO4 was added to the polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD obtained in step S2 to adjust the pH to 5, followed by the addition of 15 g / L powdered activated carbon. The mixture was stirred at 150 rpm and 40°C for 45 minutes to remove the pigment from the polyglutamic acid fermentation broth. The activated carbon was then filtered to obtain a colorless fermentation broth.
[0116] S4, nanofiltration and concentration
[0117] The colorless fermentation broth was subjected to combined nanofiltration desalination through nanofiltration membrane modules with molecular weight cutoffs of 500 Da and 1000 Da. The operating pressure was controlled at 0.5 MPa, and water (freshly prepared deionized water) was repeatedly added thereto in a volume 1.0 times that of the colorless fermentation broth. The nanofiltration was repeated 7 times until the conductivity of the permeate reached 20-100 μs / cm, the glutamic acid content was less than 5%, and the solution concentration reached 7 g / 100 ml.
[0118] S5. Remove endotoxins
[0119] The pH of the polyglutamic acid concentrate was adjusted to 5.0 by adding H2SO4 solution (6 mol / L), and then 5 g / L of ordinary activated carbon was added. The mixture was adsorbed at a stirring speed of 150 r / min and 40°C for 60 min, and the endotoxin was removed by heat preservation. The ordinary activated carbon was removed by filtration.
[0120] S6. Post-processing
[0121] After pre-cooling at -80℃ for 12 hours, use a freeze dryer to freeze-dry at a cold trap temperature of -65℃ for 12 hours. After collection, crush, sterilize and package.
[0122] Comparative Example 1
[0123] The comparative example of the present invention provides a method for separating and extracting low-endotoxin γ-polyglutamic acid, which specifically comprises the following steps:
[0124] S1, microfiltration membrane to remove bacteria
[0125] Take the newly fermented polyglutamic acid mixture, dilute it with water to a viscosity of 50 MPa·s, select a hollow fiber microfiltration membrane with a pore size of 60 nm, add it, and control the pressure of the feed port and discharge port to 0.15 MPa and 0.1 MPa respectively. Cycle water elution four times, and collect the polyglutamic acid permeate;
[0126] S2, ultrafiltration membrane ultrafiltration
[0127] The polyglutamic acid permeate in step S1 is ultrafiltered through an ultrafiltration membrane with a molecular weight cutoff of 500 kD to obtain a polyglutamic acid fermentation broth with a molecular weight greater than 500 kD, and then ultrafiltered through a 1000 kD ultrafiltration membrane to obtain a polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD;
[0128] S3, activated carbon decolorization
[0129] 6 mol / L H2SO4 was added to the polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD obtained in step S2 to adjust the pH thereof to 4, followed by the addition of 15 g / L powdered activated carbon. The mixture was subjected to adsorption treatment at a stirring speed of 120 r / min and 40° C. for 30 min to remove the pigment in the polyglutamic acid fermentation broth. Finally, the activated carbon was removed by filtration to obtain a colorless fermentation broth.
[0130] S4, nanofiltration and concentration
[0131] The colorless fermentation broth was subjected to combined nanofiltration desalination through nanofiltration membrane modules with molecular weight cutoffs of 500 Da and 1000 Da. The operating pressure was controlled at 0.2 MPa, and water (freshly prepared deionized water) was repeatedly added thereto in a volume of 0.5 times that of the colorless fermentation broth. The nanofiltration was repeated 5 times until the conductivity of the permeate reached 20-100 μs / cm, the glutamic acid content was less than 5%, and the solution concentration reached 7 g / 100 ml.
[0132] S5. Remove endotoxins
[0133] The pH of the polyglutamic acid concentrate was adjusted to 6.5 by adding H2SO4 solution (4 mol / L), followed by adding 5 g / L of 767 type medicinal activated carbon. The mixture was adsorbed at a stirring speed of 120 r / min and 40°C for 30 min, kept warm to remove endotoxins, and filtered to remove the 767 type medicinal activated carbon.
[0134] S6. Post-processing
[0135] After pre-cooling at -80℃ for 12 hours, use a freeze dryer to freeze-dry at a cold trap temperature of -65℃ for 12 hours. After collection, crush, sterilize and package.
[0136] Comparative Example 2
[0137] The comparative example of the present invention provides a method for separating and extracting low-endotoxin γ-polyglutamic acid, which specifically comprises the following steps:
[0138] S1, microfiltration membrane to remove bacteria
[0139] Take the newly fermented polyglutamic acid mixture, dilute it with water to a viscosity of 50 MPa·s, select a hollow fiber microfiltration membrane with a pore size of 60 nm, add it, and control the pressure of the feed port and discharge port to 0.15 MPa and 0.1 MPa respectively. Cycle water elution four times, and collect the polyglutamic acid permeate;
[0140] S2, ultrafiltration membrane ultrafiltration
[0141] The polyglutamic acid permeate in step S1 is ultrafiltered through an ultrafiltration membrane with a molecular weight cutoff of 500 kD to obtain a polyglutamic acid fermentation broth with a molecular weight greater than 500 kD, and then ultrafiltered through a 1000 kD ultrafiltration membrane to obtain a polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD;
[0142] S3, activated carbon decolorization
[0143] 6 mol / L H2SO4 was added to the polyglutamic acid fermentation broth with a molecular weight of 500-1000 kD obtained in step S2 to adjust the pH thereof to 4, followed by the addition of 15 g / L powdered activated carbon. The mixture was subjected to adsorption treatment at a stirring speed of 120 r / min and 40° C. for 30 min to remove the pigment in the polyglutamic acid fermentation broth. Finally, the activated carbon was removed by filtration to obtain a colorless fermentation broth.
[0144] S4, nanofiltration and concentration
[0145] The colorless fermentation broth was subjected to combined nanofiltration desalination through nanofiltration membrane modules with molecular weight cutoffs of 500 Da and 1000 Da. The operating pressure was controlled at 0.2 MPa, and water (freshly prepared deionized water) was repeatedly added thereto in a volume of 0.5 times that of the colorless fermentation broth. The nanofiltration was repeated 5 times until the conductivity of the permeate reached 20-100 μs / cm, the glutamic acid content was less than 5%, and the solution concentration reached 7 g / 100 ml.
[0146] S5. Remove endotoxins
[0147] The pH of the polyglutamic acid concentrate was adjusted to 4.0 by adding H2SO4 solution (4 mol / L), and then 5 g / L of 767 type medicinal activated carbon was added. The mixture was adsorbed at a stirring speed of 120 r / min and 40°C for 30 min, and the endotoxin was removed by heating. The 767 type medicinal activated carbon was removed by filtration.
[0148] S6. Post-processing
[0149] After pre-cooling at -80℃ for 12 hours, use a freeze dryer to freeze-dry at a cold trap temperature of -65℃ for 12 hours. After collection, crush, sterilize and package.
[0150] The endotoxin content of the polyglutamic acid permeate after treatment in step S1, the polyglutamic acid fermentation broth after treatment in step S2, the polyglutamic acid fermentation broth after treatment in step S3, the colorless fermentation broth after treatment in step S4, the colorless fermentation broth after treatment in step S5, and the product after treatment in step S6 in Example 1-2 and Comparative Example 1-2 was respectively detected using an endotoxin analyzer. The results are shown in Table 1 below.
[0151] Table 1 Endotoxin content test results of the products of Example 1-2 and Comparative Example 1-2 after treatment in each step
[0152] The extraction yield, endotoxin content, heavy metal content and purity (based on commercially available cosmetic grade) of the products prepared in Examples 1-7 were detected by HPLC, endotoxin analyzer and inductively coupled plasma mass spectrometry, respectively. The results are shown in Table 2 below.
[0153] Table 2 Extraction yield, endotoxin content and purity test results of the products prepared in Examples 1-7
[0154] The above-mentioned embodiments only express several implementation methods of the present invention. The description thereof is relatively specific and detailed, but it should not be understood as limiting the scope of the invention patent.
[0155] It should be noted that those skilled in the art may make various modifications and improvements without departing from the scope of the present invention, and these modifications and improvements fall within the scope of protection of the present invention. Therefore, the scope of protection of the patent for this invention shall be based on the appended claims.
Claims
1. A method for separating and extracting low-endotoxin γ-polyglutamic acid, characterized in that: include: S1. Microfiltration membrane removes bacteria The fermented polyglutamic acid mixed solution is added to the hollow fiber membrane microfiltration membrane, circulated and pressurized, the polyglutamic acid fermentation solution is separated into solid and liquid, and the polyglutamic acid permeate is collected; S2, ultrafiltration membrane ultrafiltration The polyglutamic acid permeate is repeatedly ultrafiltered using an ultrafiltration membrane to collect the polyglutamic acid fermentation liquid with a molecular weight of 500-1000KD; S3, activated carbon decolorization Adding H2SO4 solution to the polyglutamic acid fermentation broth until the pH thereof is 4-5, then adding powdered activated carbon, heating and stirring for decolorization, filtering to remove the activated carbon, and obtaining a colorless fermentation broth; S4, nanofiltration and concentration Taking the colorless fermentation broth, repeatedly intercepting and desalting it with a nanofiltration membrane, and then concentrating it to obtain a polyglutamic acid concentrate with a concentration of 5-7 g / 100 mL; S5. Remove endotoxins The pH of the polyglutamic acid concentrate is adjusted to 5.0-5.5 by adding H2SO4 solution, and then medicinal activated carbon is added, heated and stirred to remove endotoxins, and the medicinal activated carbon is filtered to remove the medicinal activated carbon; S6. Post-processing Vacuum freeze drying, crushing, sterilization and packaging are completed.
2. The method for separating and extracting low-endotoxin γ-polyglutamic acid according to claim 1, characterized in that: In step S3, The concentration of the H2SO4 solution is 6-10 mol / L; And / or, the added amount of the powdered activated carbon is 15-25 g / L; And / or, the stirring speed, temperature and time of the heating and stirring decolorization are 100-180 rpm, 35-45°C and 30-60min.
3. The method for separating and extracting low-endotoxin γ-polyglutamic acid according to claim 1, characterized in that: In step S5, The type and amount of the medicinal activated carbon are 767 medicinal activated carbon and 5-10 g / L respectively; And / or, the stirring speed, temperature and time of the heating and stirring to remove endotoxin are 120-150 rpm, 40-45° C. and 30-60 min respectively.
4. The method for separating and extracting low-endotoxin γ-polyglutamic acid according to any one of claims 1 to 3, characterized in that: In step S1, Before adding to the hollow fiber membrane microfiltration membrane, the viscosity of the polyglutamic acid mixture is adjusted to 50-70 Mpa·s by adding water; And / or, the pore size of the hollow fiber membrane microfiltration membrane is 50-80nm.
5. The method for separating and extracting low-endotoxin γ-polyglutamic acid according to claim 4, characterized in that: In step S1, During the circulation and pressurization process, the pressures at the feed port and the discharge port are controlled to be 0.12-0.18 MPa and 0.09-0.12 MPa, respectively, and the number of circulation and pressurization is 3-5 times.
6. The method for separating and extracting low-endotoxin γ-polyglutamic acid according to any one of claims 1 to 3, characterized in that: In step S2, Specifically, the method comprises the following steps: firstly performing ultrafiltration interception through an ultrafiltration membrane with a molecular weight cutoff of 500KD, and then performing ultrafiltration interception through an ultrafiltration membrane with a molecular weight cutoff of 1000KD to obtain polyglutamic acid fermentation liquid with a molecular weight of 500-1000KD.
7. The method for separating and extracting low-endotoxin γ-polyglutamic acid according to any one of claims 1 to 3, characterized in that: In step S4, Take the colorless fermentation broth, add water, and use a nanofiltration membrane assembly with a molecular weight cutoff of 500-1000Da, control the operating pressure to 0.1-0.5Mpa, and intercept and desalinate 5-8 times until the conductivity of the permeate is 20-100μs / cm and the glutamic acid content is less than 5wt%.
8. The method for separating and extracting low-endotoxin γ-polyglutamic acid according to any one of claim 1, characterized in that: In step S6, The vacuum freeze drying specifically includes pre-freezing at -80°C for 12-18 hours, and then using a freeze dryer to freeze at a cold trap temperature of -65°C for 12-18 hours.
9. Low-endotoxin γ-polyglutamic acid prepared by the separation and extraction method according to any one of claims 1 to 8.
10. Use of the separation and extraction method according to any one of claims 1 to 8 or the low-endotoxin γ-polyglutamic acid according to claim 9 in the preparation of a pharmaceutical-grade γ-polyglutamic acid product.
Citation Information
Patent Citations
Method for refining polyglutamic acid in biologic fermentation broth by using ultrafiltration and nanofiltration techniques
CN103665371A
Method used for fractional separation of polyglutamic acid via ultrafiltration
CN107446128A
Production method of low-endotoxin gamma-polyglutamic acid
CN114774488A
Capreomycin production system based on membrane treatment technology
CN206051902U
Isolation of poly-gamma-glutamic acid
JP1997252794A
Cited By
Refining method of sodium benzoate
CN121342648A
